EPISODE · Sep 6, 2026 · 22 MIN
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3
from Hematologic Oncology Update
Featuring perspectives from Prof John Seymour, including the following topics:Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)CME information and select publications
Embed this episode
Ready to play
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3
No transcript for this episode yet
Similar Episodes
No similar episodes found.